Descriptor English: | Dihematoporphyrin Ether | ||||||
Descriptor Spanish: |
Éter de Dihematoporfirina
| ||||||
Descriptor Portuguese: | Éter de Diematoporfirina | ||||||
Descriptor French: | Éther de dihématoporphyrine | ||||||
Entry term(s): |
DHP Ether Dihematoporphyrin Ester Ether, Dihematoporphyrin Photofrin Photofrin II Porfimer Porfimer Sodium |
||||||
Tree number(s): |
D03.383.129.578.840.500.462.400.200 D03.633.400.909.500.462.400.200 D04.345.783.500.462.400.200 D23.767.727.462.400.200 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017323 | ||||||
Scope note: | The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents Dermatologic Agents Photosensitizing Agents |
||||||
Registry Number: | 97067-70-4 | ||||||
CAS Type 1 Name: | 21H,23H-Porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21H,23H-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl- | ||||||
Previous Indexing: |
Hematoporphyrins (1985-1992) |
||||||
Public MeSH Note: | 93; DIHEMATOPORPHYRIN ETHER was indexed under HEMATOPORPHYRINS 1985-92 |
||||||
Online Note: | use DIHEMATOPORPHYRIN ETHER (NM) to search DIHEMATOPORPHYRIN ETHER 1985-92 |
||||||
History Note: | 93; was DIHEMATOPORPHYRIN ETHER (NM) 1985-92 |
||||||
Related: |
Hematoporphyrin Photoradiation
MeSH | ||||||
DeCS ID: | 30751 | ||||||
Unique ID: | D017323 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1993/01/01 | ||||||
Date of Entry: | 1992/05/20 | ||||||
Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Dihematoporphyrin Ether
- Preferred
Porfimer Sodium
- Narrower
Photofrin
- Narrower
Photofrin II
- Narrower
Concept UI |
M0026307 |
Scope note | The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States. |
Preferred term | Dihematoporphyrin Ether |
Entry term(s) |
DHP Ether Dihematoporphyrin Ester Ether, Dihematoporphyrin Porfimer |
Concept UI |
M0372990 |
Preferred term | Porfimer Sodium |
Concept UI |
M0372995 |
Preferred term | Photofrin |
Concept UI |
M0372994 |
Preferred term | Photofrin II |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey